Virbac SA (EPA:VIRP)
360.00
+5.00 (1.41%)
Apr 10, 2026, 5:35 PM CET
Virbac Revenue
In the year 2025, Virbac had annual revenue of 1.46B EUR with 4.82% growth. Virbac had revenue of 726.40M in the half year ending December 31, 2025, with 14.14% growth.
Revenue
1.46B
Revenue Growth
+4.82%
P/S Ratio
2.06
Revenue / Employee
230.11K
Employees
6,365
Market Cap
3.02B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.46B | 67.30M | 4.82% |
| Dec 31, 2024 | 1.40B | 150.48M | 12.07% |
| Dec 31, 2023 | 1.25B | 30.71M | 2.53% |
| Dec 31, 2022 | 1.22B | 152.22M | 14.31% |
| Dec 31, 2021 | 1.06B | 129.77M | 13.89% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sanofi | 46.72B |
| EssilorLuxottica Société anonyme | 28.49B |
| emeis Société anonyme | 5.77B |
| Ramsay Générale de Santé | 5.32B |
| Clariane SE | 5.31B |
| Ipsen | 3.93B |
| Sartorius Stedim Biotech | 2.97B |
| Vetoquinol | 525.70M |
Virbac News
- 4 days ago - Virbac : Declaration of the number of shares and voting rights 03/2026 - GlobeNewsWire
- 25 days ago - Virbac: Public Release of the Year-End Consolidated Accounts at 31 December 2025 - GlobeNewsWire
- 25 days ago - Virbac: 2025 annual results - GlobeNewsWire
- 4 weeks ago - Virbac : Declaration of the number of shares and voting rights 02/2026 - GlobeNewsWire
- 2 months ago - Virbac : Declaration of the number of shares and voting rights 01/2026 - GlobeNewsWire
- 4 months ago - Virbac : Declaration of the number of shares and voting rights 11/2025 - GlobeNewsWire
- 6 months ago - VIRBAC Announces Third Quarter 2025 Sales - GlobeNewsWire
- 7 months ago - Virbac: 2025 Half-year results - GlobeNewsWire